Carotid-femoral pulse wave velocity in a healthy adult sample: The ELSA-Brasil study

Imagem de Miniatura
Arquivos
art_BALDO_Carotidfemoral_pulse_wave_velocity_in_a_healthy_adult_2018.PDF (536.65 KB)
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
BALDO, Marcelo Perim
CUNHA, Roberto S.
MOLINA, Maria del Carmen B.
CHOR, Dora
GRIEP, Rosane H.
DUNCAN, Bruce B.
SCHMIDT, Maria Ines
RIBEIRO, Antonio L. P.
BARRETO, Sandhi M.
Citação
INTERNATIONAL JOURNAL OF CARDIOLOGY, v.251, p.90-95, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Aging declines essential physiological functions, and the vascular system is strongly affected by artery stiffening. We intended to define the age-and sex-specific reference values for carotid-to-femoral pulse wave velocity (cf-PWV) in a sample free of major risk factors. Methods and results: The ELSA-Brasil study enrolled 15,105 participants aged 35-74 years. The healthy sample was achieved by excluding diabetics, those over the optimal and normal blood pressure levels, body mass index <= 18.5 or >= 25 kg/m(2), current and former smokers, and those with self-report of previous cardiovascular disease. After exclusions, the sample consisted of 2158 healthy adults (1412 women). Although cf-PWV predictors were similar between sex (age, mean arterial pressure (MAP) and heart rate), cf-PWV was higher in men (8.74 +/- 1.15 vs. 8.31 +/- 1.13 m/s; adjusted for age and MAP, P < 0.001) for all age intervals. When divided by MAP categories, cf-PWV was significantly higher in those which MAP >= 85 mm Hg, regardless of sex, and for all age intervals. Risk factors for arterial stiffening in the entire ELSA-Brasil population (n = 15,105) increased by twice the age-related slope of cf-PWV growth, regardless of sex (0.0919 +/- 0.182 vs. 0.0504 +/- 0.153 m/s per year for men, 0.0960 +/- 0.173 vs. 0.0606 +/- 0.139 m/s per year for women). Conclusions: cf-PWVis different between men and women and even in an optimal and normal range of MAP and free of other classical risk factors for arterial stiffness, reference values for cf-PWV should take into account MAP levels. Also, the presence of major risk factors in the general population doubles the age-related rise in cf-PWV.
Palavras-chave
Arterial stiffness, Reference value, Healthy sample, Sex differences, Risk factors
URI
https://observatorio.fm.usp.br/handle/OPI/24892
Referências
  1. AlGhatrif M, 2017, MED CLIN N AM, V101, P81, DOI 10.1016/j.mcna.2016.08.006
  2. AlGhatrif M, 2013, HYPERTENSION, V62, P934, DOI 10.1161/HYPERTENSIONAHA.113.01445
  3. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  4. BALDO MP, 2017, J AM HEART ASS, V6
  5. Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381
  6. Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111
  7. Bossuyt J, 2015, J HYPERTENS, V33, P1997, DOI 10.1097/HJH.0000000000000655
  8. Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653
  9. Chor D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127382
  10. Diaz A, 2014, INT J HYPERTENS, DOI 10.1155/2014/653239
  11. Farro I, 2012, INT J HYPERTENS, DOI 10.1155/2012/169359
  12. Gavish B., 2016, AM J HYPERTENS
  13. Khoshdel AR, 2006, J HYPERTENS, V24, P1231, DOI 10.1097/01.hjh.0000234098.85497.31
  14. Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
  15. Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236
  16. Laurent S, 2007, HYPERTENSION, V49, P1202, DOI 10.1161/HYPERTENSIONAHA.106.076166
  17. Laurent S, 2012, J HYPERTENS, V30, pS3, DOI 10.1097/HJH.0b013e328353e501
  18. Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165
  19. Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
  20. Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98
  21. Nakano Hiroshi, 2001, Journal of Nippon Medical School, V68, P490, DOI 10.1272/jnms.68.490
  22. Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064
  23. Payne RA, 2010, HYPERTENSION, V55, P9, DOI 10.1161/HYPERTENSIONAHA.107.090464
  24. Sarafidis PA, 2017, HYPERTENSION, V70, P148, DOI 10.1161/HYPERTENSIONAHA.117.09023
  25. Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
  26. Schmidt MI, 2013, REV SAUDE PUBL, V47, P105, DOI 10.1590/S0034-8910.2013047003889
  27. Smulyan H, 2016, J AM SOC HYPERTENS, V10, P175, DOI 10.1016/j.jash.2015.11.012
  28. Sun ZJ, 2015, HYPERTENSION, V65, P252, DOI 10.1161/HYPERTENSIONAHA.114.03617
  29. Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5
  30. TOMIYAMA H, 2017, J AM HEART ASS, V6
  31. Veronese FV, 2014, CLIN CHEM LAB MED, V52, P1747, DOI 10.1515/cclm-2014-0052
  32. Vlachopoulos C, 2015, ATHEROSCLEROSIS, V241, P507, DOI 10.1016/j.atherosclerosis.2015.05.007
  33. Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061
  34. Yun MY, 2015, J HYPERTENS, V33, P266, DOI 10.1097/HJH.0000000000000410

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/13
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03